Keytruda 100 MG/4 ML vial 4ML
Ended Awarded
- Contract number
- SPE2DB25FDM42
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $409,478
Award facts
- Contract value 100% obligated
- $409,478.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $409,478 by the Defense Logistics Agency on September 29, 2025. The contract calls for the delivery of Keytruda (pembrolizumab) 100 mg/4 mL vials, an oncology medication commonly used in cancer treatment. This delivery order was issued without a set-aside designation and is scheduled for ultimate completion by October 21, 2025, with performance occurring at the company's Park Ridge facility.
This delivery order is issued under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with the Defense Logistics Agency valued at approximately $500 million and valid through November 2026. Through this master contract vehicle, the company serves as a critical supplier within the federal pharmaceutical supply chain, providing a comprehensive range of pharmaceutical products including branded and generic prescription drugs, biologics, and medical consumables to Department of Defense healthcare facilities worldwide. DMS Pharmaceutical Group's established portfolio of federal contracts demonstrates consistent success in competing for pharmaceutical supply contracts without set-aside designations, leveraging its status as a woman-owned small business to support military health operations.
Quick answers
Who was awarded contract SPE2DB25FDM42?
SPE2DB25FDM42 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 29, 2025.
How much is contract SPE2DB25FDM42 worth?
The government has obligated $409,478 on SPE2DB25FDM42.
Is contract SPE2DB25FDM42 an order under another contract?
Yes. SPE2DB25FDM42 is a delivery order under SPE2DB22D9239, an indefinite delivery contract.
Was contract SPE2DB25FDM42 competed?
The extent of competition for SPE2DB25FDM42 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award